Ephedra Ban Court Challenge Could Be Good News For FDA, Win Or Lose
This article was originally published in The Tan Sheet
Executive Summary
FDA's decision to ban ephedra outright creates a win-win situation for the agency, regardless of whether the regulation stands up in court
You may also be interested in...
Ephedra Ban Effective In April; FDA Will Follow-Up On Internet Firms
A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6
DSHEA Implementation Action Expected In Second Session Of 108th Congress
A House version of the Dietary Supplement Health & Education Act "Full Implementation" Senate bill is expected early this year, marking the impact of industry efforts to respond to a challenging year in Washington
FDA Regulatory Framework For Ephedra Ban Expected To Get Court Review
FDA's regulatory framework for removing dangerous dietary supplements from the market under the Dietary Supplement Health & Education Act's "unreasonable risk" standard will be issued shortly by the agency